Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TCRT stock hub

Alaunos Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TCRTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

TCRT

In the news

Latest news · TCRT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-198.1

P25 -105.6P50 -46.5P75 -3.1

ROIC-125.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TCRT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

193

Groups with data

Currency

USD

Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001107421
Company name	Alaunos Therapeutics, Inc.
Country	United States
Country code	US
Cusip	98973P101
Employees	1
Employees Change	-33%
Employees Change Percent	-97.06
Enterprise value	$4.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US98973P3091
Last refreshed	2026-05-10
Market cap	$6.1M
Market cap category	Nano-Cap
Price	$2.58
Price currency	USD
Rev Per Employee	5,000x
Sector	Healthcare
Sic	2834
Symbol	TCRT
Website	https://www.alaunos.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-69.79%
EV/Sales	950.18x
FCF yield	-48.35%
P/B ratio	2.82x
P/S ratio	1,227.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-1.4M
Net Income	$-4.3M
Net Income Growth Years	6%
Pretax Margin	-83,520%
Profit Per Employee	$-4.3M
ROA	-92.31
Roa5y	-51.82
ROCE	-196.2
ROE	-198.1
Roe5y	-126.2
ROIC	-125.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-45.17%
Cagr15y	-32.84%
Cagr1y	-10.11%
Cagr20y	-25.35%
Cagr3y	-69.14%
Cagr5y	-64.84%
EPS Growth Quarters	17
EPS Growth Years	6
Revenue Growth	-50x
Revenue Growth Q	-25x
Revenue Growth Years	0x
Revenue Growth3 Y	-88.04x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$3M
Cash	$1.4M
Current Assets	$2M
Current Liabilities	$813,000
Equity	$2.2M
Liabilities	$813,000
Long Term Assets	$978,000
Long Term Liabilities	$0
Net Cash	$1.4M
Net Cash By Market Cap	$22.57
Net Cash Growth	26.95%
Net Debt Equity	$-0.64
Tangible Book Value	$2.2M
Tangible Book Value Per Share	$0.92
WACC	-1.94

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.45
Net Working Capital	$-210,000
Quick ratio	1.71
Working Capital	$1.2M
Working Capital Turnover	$0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-21.68%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.75%
1Y total return	-10.1%
200-day SMA	2.9
3Y total return	-97.06%
50-day SMA	2.99
50-day SMA vs 200-day SMA	50over200
5Y total return	-99.46%
All Time High	2,239.5
All Time High Change	-99.88%
All Time High Date	2015-11-10
All Time Low	1.31
All Time Low Change	96.35%
All Time Low Date	2025-03-31
ATR	0.17
Beta	-1.13
Beta1y	-0.77
Beta2y	-1.77
Ch YTD	-20.12
High	2.62
High52	6.2
High52 Date	2025-07-14
High52ch	-58.39%
Low	2.58
Low52	1.67
Low52 Date	2025-08-22
Low52ch	54.49%
Ma50ch	-13.6%
Premarket Change Percent	-0.26
Premarket Price	$2.66
Price vs 200-day SMA	-11.1%
RSI	38.82
RSI Monthly	36.84
RSI Weekly	43.24
Sharpe ratio	0.28x
Sortino ratio	0.49
Total Return	-21.68%
Tr YTD	-20.12
Tr15y	-99.75%
Tr1m	-11.64%
Tr1w	-1.15%
Tr3m	-1.9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-4.2M
Operating margin	-84,500

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,867,898%
Float Percent	78.54%
Shares Insiders	21.46%
Shares Institutions	7.19%
Shares Out	2,378,253
Shares Qo Q	6.55%
Shares Yo Y	21.68%
Short Float	0.66%
Short Ratio	0.68
Short Shares	0.52

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-3.4M
Average Volume	12,622.05x
Bv Per Share	0.92
CAPEX	$-98,000
Ch10y	-99.75
Ch15y	-99.75
Ch1m	-11.64
Ch1w	-1.15
Ch1y	-10.1
Ch20y	-99.71
Ch3m	-1.9
Ch3y	-97.06
Ch5y	-99.46
Ch6m	4.88
Change	-3.26%
Change From Open	-1.53
Close	2.67
Days Gap	-1.76
Depreciation Amortization	7,000
Dollar Volume	8,613.1
Earnings Date	2026-05-12
Earnings Time	amc
EBIT	$-4.2M
EBITDA	$-4.2M
EPS	$-2.2
F Score	1
FCF	$-3M
FCF EV Yield	-62.45x
FCF Per Share	$-1.25
Financing CF	3,261,000
Fiscal Year End	December
Founded	1,998
Investing CF	-98,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Last Split Date	2024-07-18
Last Split Type	Reverse
Last10k Filing Date	2026-03-31
Ma150	3.06
Ma150ch	-15.69%
Ma20	2.72
Ma20ch	-5.29%
Net CF	294,000
Next Earnings Date	2026-05-22
Open	2.62
Optionable	No
Position In Range	0
Post Close	2.58
Postmarket Change Percent	3.1
Postmarket Price	$2.66
Ppne	91,000
Pre Close	2.67
Price Date	2026-05-08
Ptbv Ratio	2.85
Relative Volume	0.26x
Revenue	5,000x
SBC By Revenue	8,280x
Share Based Comp	414,000
Tr20y	-99.71%
Tr6m	4.88%
Us State	Florida
Volume	3,338.4
Z Score	-436.8

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TCRT pay a dividend?

Capital-return profile for this ticker.

Performance

TCRT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TCRT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.2%

Float: +78.5% of shares outstanding

Insider ownership

+21.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TCRT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.8

Neutral momentum band

Price vs 200-day MA

-11.1%

50/200-day relationship not available

Beta (5Y)

-1.13

Less volatile than the market

Sharpe ratio

0.28

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TCRT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current TCRT stock rating?

Alaunos Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full TCRT analysis?

The full report lives at /stocks/TCRT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for TCRT?

The latest report frames TCRT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the TCRT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.